Abstract Oxidative stress plays an important role in the progression of HIV-1 infection. Nicotine can either protect neurons from neurodegeneration or induce oxidative stress, depending on its dose and degree of oxidative stress impairment. However, the relationship between nicotine and oxidative stress in the HIV-1-infected individuals remains largely unknown. The purpose of this study was to determine the effect of nicotine on expression of genes related to the glutathione (GSH)-centered antioxidant system and oxidative stress in the nucleus accumbens (NAc) and ventral tegmental area (VTA) of HIV-1 transgenic (HIV-1Tg) and F344 control rats. Adult HIV-1Tg and F344 rats received nicotine (0.4 mg/kg, base, s.c.) or saline injections once per day for 27 days. At the end of treatment, various brain regions including the NAc and VTA were collected from each rat. Following total RNA extraction and complementary DNA (cDNA) synthesis of each sample, quantitative reverse transcription PCR (RT-PCR) analysis was performed for 43 oxidative-stress-related genes. Compared with F344 control rats, HIV-1Tg rats showed a significant downregulation of genes involved in ATPase and cyctochrome oxidase at the messenger RNA (mRNA) level in both regions. Further, we found a significant downregulation of Gstm5 in the NAc and upregulation of Cox1, Cox3, and Gsta6 in the VTA of HIV-1Tg rats. HIV-1Tg rats showed brain-region-specific responses to chronic nicotine treatment. This response resulted in a change in the expression of genes involved in antioxidant mechanisms including the downregulation of genes such as Atp5h, Calml1, Gpx7, Gstm5, Gsr, and Gsta6 and upregulation of Sod1 in the NAc, as well as downregulation of genes like Cox5a, Gpx4, Gpx6, Gpx7, Gstm5, and Sod1 in the VTA of HIV-1Tg rats. Together, we conclude that chronic nicotine treatment has a dual effect on the antioxidant defense system and oxidative-stress-induced apoptosis signaling in HIV-1Tg rats. These findings suggest that nicotine has a negative effect on response to oxidative stress and antioxidant processes in HIV-1 Tg rat brain, especially in the VTA.
Introduction
The central nervous system (CNS) is one of the major targets of the human immunodeficiency virus (HIV-1) and exhibits high vulnerability to HIV-1-mediated pathogenesis (Churchill et al. 2014) . HIV-1 proteins can directly cross the blood-brain barrier (BBB) and exert effects on the brain in early stages of HIV-1 infection (Kaul et al. 2005; Kimura et al. 1993) . HIV-1 proteins affect the activation of monocytic cells (e.g., microglia, macrophages, and astrocytes), leading to the increased production of neuroactive and neuroimmune products in the brain (Kimura et al. 1993) . Several lines of evidence suggest that an increased inflammatory response to viral proteins can facilitate the activation of oxidative stress and apoptosis signaling cascades (Kaul et al. 2005; Kimura et al. 1993 ). In addition, HIV-1 proteins induce mitochondrial dysfunction by directly interacting with mitochondrial membrane proteins, leading to high levels of oxidative stress in neurons (Ladha et al. 2005) . Alterations in mitochondrial function and oxidative stress have been suggested as key mediators in developing HIV-1-associated neurocognitive disorders (HAND) during late stage of HIV-1-infected patients (Perez-Matute et al. 2013) .
Nicotine is an agonist of nicotinic acetylcholine receptors (nAChRs) and a major psychoactive component in tobacco smoke (Levin et al. 2014 ). However, research on the neuroprotective and neurotoxic effects of nicotine in the CNS has been inconclusive (Nie et al. 2013; Nordberg et al. 2002; Picciotto and Zoli 2008; Zeng et al. 2001) . For example, nicotine has been shown to produce significant improvement in the attention span and memory performance in both human and animal studies (Knott et al. 2012; Levin et al. 2014 ) and has been implicated in neuroprotective effects against β-amyloid-mediated neurotoxicity as well as the enhanced neuroplasticity in transgenic model for Alzheimer's disease in mice (Nie et al. 2013 ). These effects are likely mediated by upregulation of nAChR expression and decrease in the accumulation of β-amyloid peptide leading to a decrease in neurotoxicity (Kihara et al. 1997; Nordberg et al. 2002; Picciotto and Zoli 2008; Zeng et al. 2001) . On the other hand, nicotine has been shown to modulate expression of multiple immune-related pathways in SH-SY5Y cells (Cui et al. 2012) . The effect of nicotine on immune function was also demonstrated in mitochondrial signaling pathways by inhibiting chemotherapy-induced apoptosis in lung cancer (Zhang et al. 2009 ). There is also considerable evidence from in vivo and in vitro studies, showing that nicotine increases oxidative stress and consequently neuronal cell death (Guan et al. 2002; Quik et al. 2007; Soto-Otero et al. 2002) . Under oxidative stress conditions, neurons increase their antioxidant defense mechanisms by enhancing the production and release of free radical scavengers. This alternation enhances the survival of neurons through the activation of glutathione (GSH) and antioxidant enzymes like catalase and superoxide dismutase (SOD).
Further, nicotine has also been shown to disrupt the antioxidant defense mechanisms by decreasing levels of GSH and SOD in rats and altering the balance between antioxidant capacity and oxidative-stress-induced free radicals in the brain (Guan et al. 2002; Soto-Otero et al. 2002; Wang et al. 2009; Yildiz et al. 1998) . The interaction between nicotine and oxidative stress mechanisms is also detected in the lipid peroxidation mechanism which is initiated by free radical reactions from mitochondria. Nicotine is reported to stimulate lipid peroxidation by increasing the malondialdehyde (MDA) and lactate dehydrogenase in CHO cells (Yildiz et al. 1998) . The decrease in the antioxidant defense system and increase in the production of reactive oxygen species have been implicated in many forms of neurodegenerative diseases such as Parkinson's disease (PD) and Alzheimer's disease (AD) (Subramaniam and Chesselet 2013; Uttara et al. 2009 ).
Epidemiological studies have revealed an inverse correlation between smoking and the incidences of AD and PD (Picciotto and Zoli 2008; Zhang et al. 2009 ). Although studies have clearly shown the importance of mitochondria in the biological response to nicotine in these disease states, the relationship between nicotine and oxidative stress in these diseases, especially in HIV-1-infected individuals, remains largely unknown. To better understand the possible neuroprotective and neurotoxic effects of nicotine in HIV-1 patients, we compared the effect of nicotine on the expression of genes related to the (GSH)-centered antioxidant system and oxidative stress in dopaminergic midbrain regions of HIV-1 transgenic (HIV-1Tg) and F344 control rats.
Materials and methods

Animals
Adult male HIV-1Tg and F344 control rats were purchased from Harlan Inc. (Indianapolis, IN). All rats were maintained under controlled lighting (12:12 light/dark) and temperature (20°C) with ad libitum access to food and water. All animal experiments reported in this study were approved by the Animal Care and Use Committee of University of Virginia.
Nicotine treatment
Nicotine hydrogen bitartarate (Sigma Aldrich Co., St. Louis, MO) was dissolved in 0.9 % w/v NaCl solution (saline) and neutralized to pH 7.2∼7.0 with NaOH. Rats from each strain were divided randomly into two groups (n = 6 per group): control (i.e., HIV-1Tg_saline or F344_saline control) and nicotine treatment group (i.e., HIV-1Tg_nicotine-treated and F344_nicotine-treated groups). Either nicotine (0.4 mg/kg, base) or saline was administered once a day at 9:00 a.m. by subcutaneous injection for 27 days. This drug treatment paradigm was based on previous reported behavioral studies (Matta et al. 2007; Menon 2001a ) and our own reported study where we showed that the 27 days of 0.4 mg/kg dose of nicotine given subcutaneously to HIV-1Tg rats leads to significant changes of gene expression in the brain (Nesil et al. 2015) . Furthermore, previous studies have also shown that more than 20 days of nicotine injection leads to oxidative stress and tissue injury (Sener et al. 2004 (Sener et al. , 2005 .
Tissue collection
Animals were killed 1 day after the last injection, and brains were immediately removed after decapitation. Using a rat brain matrix, brain slices of approximately 1 mm were taken from each brain. Tissues from the ventral tegmental area (VTA) and nucleus accumbens (NAc) were collected bilaterally from each brain using a 3.00-mm Harris Micro-Punch (GE Healthcare Life Sciences, Piscataway, NJ, USA) according to the rat brain atlas (Paxinos and Watson 1998) . Punched tissues were stored at −80°C until use.
Quantitative RT-PCR array analysis
Total RNA was isolated from punched brain tissues using the Trizol reagent (Life Technologies, Grand Island, NY) according to the manufacturer's protocol. The quantity and purity of the extracted total RNA were measured at the optical densities of 260 and 280 nm with NanoDrop 2000c (Thermo Fisher Scientific, Waltham, MA). The primers for each gene of interest were designed using Primer Express (v. 3.0) software (Applied Biosystems, Carlsbad, CA, USA) and spanned introns to avoid amplifying genomic DNA, with a melting temperature (Tm) from 59 to 61°C. The amplicon sequences were subjected to a BLAST search to ensure the specificity of the primers for the target genes of interest. All the primers were tested for their specificity by checking the cycle number and the dissociation curve before they were included in the quantitative reverse transcription PCR (qRT-PCR) array. The primer sequencers of all examined genes in this study are listed in Table 1 .
First-strand complementary DNAs (cDNAs) were synthesized from 2 μg of total RNA using a Reverse Transcription System Kit (Promega, Madison, WI). The qRT-PCR analysis was conducted as described previously . Briefly, RT product was amplified in a volume of 10 μl containing 5 μl 2× Power SYBR Green PCR Master Mix (Applied Biosystems, CA, USA), equally mixed sense and antisense primers (with a final concentration 250 nM each), and 2.5 μl diluted cDNA in a 384-well plate using the 7900HT Fast Real Time PCR system (Applied Biosystems) (Cui et al. 2012; Wang et al. 2011) . The PCR condition was as follows: 95°C for 10 min, followed by 40 cycles of 95°C for 15 s, and 60°C for 1 min. A cycle threshold (C t ) was assigned in the beginning of logarithmic phase of amplification, and difference in C t values of the control and treated groups was used to determine the relative expression. Melting curve analysis was applied to characterize the specificity of the amplicons.
Statistical analysis
Expression levels of all genes of interest were first normalized to the expression of housekeeping gene glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and then analyzed using a comparative C t method (Winer et al. 1999; Zhao et al. 2014 ). The relative gene expression level was compared between F344 and HIV-1Tg rats using the Student's t test. A significant alteration in messenger RNA (mRNA) expression level was defined as a fold change >20 % with a P value <0.05.
Results
Strain differences in the expression of genes related to oxidative stress and mitochondrial function
There is a large body of evidence revealing that HIV-1 proteins induce mitochondrial dysfunction as a result of increased oxidative stress which has been implicated in several types of neuropathogenesis of HIV-1 infection in the brain (Churchill et al. 2014; Perez-Matute et al. 2013) . Considering the effects of HIV-1 proteins on the mitochondrial function and oxidative stress, we examined the expression profiles of 43 genes involved in electron transport chain including ubiquinone oxidoreductase (i.e., mitonchondrial complex I), succinate dehydrogenase (mitonchondrial complex II), cytochrome bc1 complex (mitonchondrial complex III), cytochrome c oxidase (mitonchondrial complex IV), apoptosis, antioxidant activity, and ATP transporters in the NAc and VTA regions of HIV1Tg and F344 control rats. Our statistical analysis of mRNA expression data in the HIV-1Tg and F344 rats at the cutoff ratio of >20 % mRNA fold change revealed that 9 genes in the NAc (Table 2 ) and 12 genes in the VTA (Table 3) showed significant gene expression differences in HIV-1Tg rats compared to F344 rats. In the NAc, expression levels of the genes in mitochondrial complex I (Ndufa2, P=0.0004; Ndufb2, P= 0.009), complex IV (Cox5a, P=0.018; Cox6a, P=0.007), and ATPase in complex V (Abcd2, Atp5h, and Atp6v1f; P= 0.001-0.05) were significantly downregulated by viral proteins. We also found a significant downregulation of the expression of antioxidant enzyme glutathione S-transferase subunit Gstm5 in the NAc of HIV-1Tg rats.
The calcium signals and activation of Ca +2 /calmodulin-dependent kinase signaling lead to mitochondrial reactive oxygen species (ROS) generation and are critical in oxidativestress-induced neuronal apoptosis. The impact of mitochondrial dysfunction on intracellular calcium levels has been reported in neurodegenerative diseases (Subramaniam and Chesselet 2013) . Our results indicated that expression of calcium binding protein calmodulin 1 (Calm1) in the VTA, which functions as a calcium-binding protein and activates calmodulin-dependent kinases, was 45.8 % higher in HIV1Tg rats than that in F344 rats (P=0.042; Table 2 ).
In the VTA (Table 3) , HIV-1 proteins significantly downregulated the expression of genes in the mitochondrial complex I (Ndufa2, Ndufb2, and Ndufa8; P<0.05 for all of them) and complex V (Abcd2, Atp5h, and Atp6v1f; P<0.05 for all of them). We found a biphasic expression pattern of cyctochrome oxidase in mitochondrial complex IV encoding genes where expression of Cox1 and Cox3 mRNA was increased by 28.4 and 35.6 % (P=0.021 for both genes), respectively. The expression of Cox8b was decreased by 48 % in mRNA expression (P=0.021) in VTA. In addition, genes associated with antioxidant defense (Gsta6; P=0.045) and the p53-dependent apoptosis pathway (Perp; P = 0.033) showed a significant increase of mRNA expression in the VTA of HIV-1Tg rats (Table 3 ).
The effects of HIV-1 proteins and nicotine on the mRNA expression in the NAc and VTA of HIV-1Tg rats
The role of oxidative stress in midbrain dopaminergic cell loss has been indicated to be one of the major causes of neurodegeneration during HIV-1 infection (Nath et al. 2000) . Since nicotine has a dual effect on induction of oxidative stress and neuroprotection, we next examined whether nicotine can potentiate mitochondrial-dysfunction-mediated oxidative stress caused by viral proteins in the NAc and VTA of HIV-1Tg rats. Chronic nicotine treatment significantly modified the mRNA expression levels in the HIV-1Tg rats; this effect was more pronounced in the GSH-centered antioxidant system-related genes in the NAc and VTA. As shown in Table 4 and Fig. 1 /calmodulin-dependent kinase signaling (Calm1; P=0.005).
In the VTA, nicotine significantly modulated the expression of genes in the apoptosis signaling, antioxidant defense system, and mitochondrial complex IV in the HIV-1Tg rats. The expression levels of the genes in the GSH-centered antioxidant system (Gpx4, Gpx6, Gpx7, Gstm5) and superoxide dismutase encoding Sod1 were significantly downregulated by 18.7-73.3 % (P=0.02-0.04) in the nicotine-treated HIV1Tg rats compared to the saline-treated HIV-1Tg rats (Fig. 1) . Similarly, expression level of Cox5a in complex IV was significantly downregulated by nicotine in the VTA of HIV-1Tg rats (27.9 %; P=0.038). Different from the observed effect in the NAc, chronic nicotine treatment significantly increased the expression of the genes involved in apoptosis signaling, including pro-apoptotic gene (Casp9; 28.1 %; P=0.001) and apotosis facilitator (Bcl2L11; 26.7 %; P=0.009, Table 4 , bottom panel).
Nicotinic modulation of oxidative-stressand mitochondrial-function-related gene expression in F344 rats
Previous studies have shown that nicotine has neuroprotective effects in the CNS during neurodegeneration (Quik et al. 2007). To determine whether nicotine induces oxidative stress or has a positive effect on the antioxidant system under normal physiological conditions, we compared the same set of genes involved in oxidative stress, antioxidant defense mechanism, apoptosis signaling, and mitochondrial function between saline and nicotine treatment groups in F344 rats. Nicotine significantly increased the mRNA expression of the gene encoding superoxide dismutase antioxidant enzyme (Sod1; 93.5 %; P=0.034) but decreased the glutathione peroxidase 1 (Gpx1) mRNA expression (31.9 %; P=0.005) in the NAc (Table 5) .
In contrast to the observed effects of nicotine in the HIV1Tg rats, genes encoding the GSH-centered antioxidant system members (Gpx4, Gpx5, Gpx7, Gstk1, and Gsta6) were significantly upregulated (27-150 %; P=0.02-0.008) by nicotine in the VTA of F344 rats. However, antioxidant enzyme superoxide dismutase encoding gene Sod2 was significantly downregulated (23.4 %; P=0.01) by nicotine treatment. Our results also indicated a significant increase in the expression of Casp8 (42.1 %; P=0.031) in the apoptosis signaling pathway and of apoptosis facilitator Perp gene (24.2 %; P=0.035) by nicotine in the VTA of F344 rats (Table 5 ). NAc nucleus accumbens, VTA ventral tegmental area, SEM standard error of the mean Fig. 1 Brain-region-specific effects of nicotine on the expression of genes in the glutathione-centered antioxidant defense system and apoptosis signaling in the NAc (left panel) and VTA (right panel) of HIV-1Tg rats. The relative quantity is presented in a log 10 scale. Bars indicate mean±SEM. Statistical comparisons were made using twotailed, unpaired Student's t test between saline control and nicotinetreated groups. HS = saline-treated HIV-1Tg rats; HN = nicotine-treated HIV-1Tg rats (n=4-6 per group)
Discussion
We demonstrated the effects of HIV-1 proteins and nicotine on the expression of genes associated with mitochondrial function and the antioxidant defense system in the VTA and NAc of HIV-1Tg and F344 rats. Results showed that HIV-1 proteins disrupted mitochondrial function through mitochondrial complexes I-V and showed a brain-region-specific effect on the expression of glutathione-centered antioxidant enzymes in the NAc and VTA. We also found that a moderate dose of nicotine partially attenuated the effects of HIV-1 proteins in the NAc and potentiated the effects of viral proteins on oxidative stress and apoptosis signaling in the VTA. Further, chronic nicotine treatment showed brain-region-specific effects on the expression of genes associated with the antioxidant defense system. A significant increase was observed in the expression of genes in the GSH antioxidant system in the VTA and expression of superoxide dismutase in the NAc of F344 control rats. Alterations in mitochondrial function play a major role in the development and progression of neurodegenerative disorders, including HAND (Lee et al. 2010; Stack et al. 2008) . HIV-1 proteins induce oxidative stress by decreasing the activity of mitochondrial complexes I-V and increasing the production of ROS in the brain (Aksenov et al. 2001; Ladha et al. 2005; Mollace et al. 2001) . Previous studies have shown that HIV-1 proteins (e.g., gp120 and Tat) preferentially decrease mitochondrial function and increase the neurotoxicity in the midbrain dopaminergic neurons (Aksenov et al. 2001) . The current study showed that HIV-1 proteins induced mitochondrial dysfunction in the NAc and VTA by altering the expression profiles of genes in mitochondrial complexes I-V. The genes involved in complex I showed lower expression levels in the NAc (Ndfun2a) and VTA (Ndfub2, Ndfub8, and Ndfub2a) of HIV-1Tg rats. Impaired complex I activity has been shown in HIV-1-induced apoptosis in T cells (Tripathy and Mitra 2010) . The decrease in the expression of complex I subunit Ndufa6 has been reported to have a role in the mitochondrial dysfunction during HIV-1 infection (Ladha et al. 2005) . Among the mitochondrial respiratory chain complexes, alterations in the activity of complex IV have an important role in mediating the effects of HIV-1 proteins on oxidative stress. Miro et al. (2004) showed that complex IV activity was decreased by 19 % in the mononuclear cells of HIV-1-infected patients. In contrast, Tripathy and Mitra (2010) reported that an upregulation of Cox2, a subunit of complex IV, with a concomitant increase in HIV-1 induced apoptosis in T cells. In our analysis of the gene expression in HIV-1Tg rats, the complex IV subunits Cox5a and Cox6a in the NAc and Cox8a in the VTA displayed low expression levels in the HIV-Tg rats compared to those in F344 rats.
Mitochondrial ATP synthase (complex V) activity has a pivotal role in energy metabolism of neurons (Chaban et al. 2014) . Decreased activity in complexes I-IV and increased oxidative stress are defined as important factors in the impairment of mitochondrial ATP synthase activity (Mollace et al. 2001; Navarro and Boveris 2010) . There is a strong relationship between deprivation of energy metabolism and ROS production; however, the interaction between excessive ROS production and the decline of mitochondrial ATP synthesis in the midbrain has not been fully investigated during HIV-1 infection. In the current study, our results indicate a possible dysfunction in the complex V due to the reduced expression levels of ATPase subunits in the midbrain regions of HIV1Tg rats. The expression levels of Abcd2, Atp5h, and ATP6v1f genes were significantly downregulated by HIV-1 proteins in the NAc and VTA. These results indicate that HIV-1 proteins can alter energy metabolism through both complexes I and IV and increase ROS production in the midbrain. The interaction between ROS and the antioxidant defense system has been shown in the molecular mechanisms of HIV-1-associated neurocognitive disorders (Mollace et al. 2001; Price et al. 2005) . Depletion of the antioxidant defense system leads to an accumulation of ROS in the mitochondria (Mollace et al. 2001; Price et al. 2005 ). This alteration increases the formation of apoptosome complex. This formation activates caspase-9-mediated apoptotic signaling cascades during neurodegeneration (Fratiglioni and Wang 2000) . HIV-1 proteins trigger the apoptotic signaling cascades by decreasing the levels of antioxidant enzymes with uncompensated ROS production (Louboutin et al. 2012) . Our results partially confirm the aforementioned findings and show that HIV-1 proteins decreased the expression of antioxidant enzymes in the NAc (Gstm5) and upregulated the Gsta6 in the VTA. Our results also showed the effect of HIV-1 proteins on the expression of genes in apoptotic signaling cascades in both VTA and NAc. Compared to F344 rats, HIV-1Tg rats showed higher expression of Perp, which is linked to P53-dependent apoptosis signaling, and lower expression levels of proapoptotic caspase-9. The loss of mitochondrial calcium buffering capacity triggers calmodulin-dependent apoptosis signaling pathways in the brain. Also, we showed that HIV-1 proteins increased the calmodulin expression in the NAc, suggesting the interaction of mitochondrial dysfunction and calcium in the loss of dopaminergic neurons.
Previous studies have revealed the dual effects of nicotine on oxidative stress and neurodegenerative disorders (Picciotto and Zoli 2008; Wang et al. 2009 ). It has been reported that the dose, route of treatment, and the degree of oxidative stress determine the action of nicotine in the brain during neurodegeneration. A low dose of nicotine showed neuroprotective effects depending on activation kinetics of nAChR subunits and localization of the pathogenesis in the brain (Picciotto and Zoli 2008) . On the other hand, a high dose of nicotine showed neurotoxic effects, which trigger oxidative stress in the CNS resulting in neuronal loss in the midbrain and cortex (Gallo et al. 2010; Ravikumar et al. 2004) . By examining the effect of a moderate dose of nicotine (0.4 mg/kg, base, s.c.) after 27 days of chronic treatment on the expression of genes in the mitochondrial complexes, antioxidant defense system, and apoptosis signaling in the HIV-1Tg rats, we found that nicotine under this moderate dose had a biphasic effect, i.e., exhibiting antioxidant activities in the NAc and neurotoxic effects in the VTA. Chronic nicotine treatment upregulated Sod1 expression and downregulated the genes in the glutathionecentered antioxidant defense system in the NAc of HIV-1Tg rats. In the VTA, genes encoding the subunits of antioxidant enzymes were downregulated by nicotine in the HIV-1Tg rats. The balance between oxidant species and removal of oxidants by the antioxidant enzymes determines the ROS-mediated apoptosis signaling in neurons. Multiple in vitro and in vivo studies have demonstrated the neuroprotective effect of Sod1 overexpression in neurodegeneration including HAND (Boven et al. 1999; Louboutin et al. 2012) . Results demonstrated that increased levels of Sod1 induced a decrease in ROS levels that lead to an enhanced resistance to caspase-mediated apoptosis in neurons. In contrast to the previous findings (Picciotto and Zoli 2008; VanCott et al. 1997) , our results showed that a moderate dose of chronic nicotine treatment exhibited neurotoxic effects in the VTA of HIV-1Tg rats.
The discrepancies in the protective effects of nicotine might be related to differences in the oxidative stress levels and actions of HIV-1 proteins in the VTA. There is increasing evidence suggesting the involvement of free radicals and iron (Fe)-induced oxidative stress in the pathogenesis of PD, AD, and HIV-1-associated neurodegeneration (Tolnay et al. 1997) . The increased levels of Fe and degeneration of nigrostriatal dopaminergic neurons have been determined to be a future characteristic of PD (Marshall et al. 2011) . Moreover, the effect of HIV-1 proteins on Fe levels was demonstrated in primary human fetal adrenocortical (HFA) cells (Kaul et al. 2005) . Results showed that viral proteins increased the concentration of ferritin (important role in the storage of Fe) and oxidative stress. Our results also showed that nicotine could alter the Fe (II) and H 2 O 2 levels by increasing the formation of 6-hydroxydopamine (6-OHDA) which is formed through the oxidation of dopamine by Fe (II) and H 2 O 2 in Fenton's reaction (Kimura et al. 1993; Linert et al. 1999) . Given this evidence, the effect of nicotine and HIV-1 proteins in the molecular mechanisms of oxidative stress signaling, we propose that nicotine potentiates the effect of HIV-1 proteins by stimulating dopaminergic neurons in the VTA. This stimulation may increase dopamine production and release from the VTA which contributes to excessive production of Fenton reagents and depletes antioxidant enzyme activity.
Taken together, our results show that a moderate dose of chronic nicotine treatment partially attenuates the effect of HIV-1 proteins in the NAc by upregulating Sod1 expression levels. However, nicotine potentiates the neurotoxic effects of HIV-1 proteins and stimulates oxidative stress in the VTA of HIV-1 Tg rats.
We also evaluated nicotine's effects on mitochondrialfunction-and oxidative-stress-induction-related genes under normal physiological conditions by exposing F344 rats to chronic nicotine treatment. Our results showed that nicotine altered the expression of antioxidant-defense-mechanismrelated genes in a brain-region-specific manner. A moderate dose of chronic nicotine treatment decreased the expression of glutathione-centered antioxidant enzyme Gpx1 and increased the Sod1 expression in the NAc of F344 rats. In contrast, nicotine increased the expression levels of glutathionecentered antioxidant defense system enzymes (Gsta6, Gpx4, Gpx5, Gpx7, and Gstk1) and decreased Sod1 expression levels in the VTA. In fact, nicotine enhanced the expression of genes involved in p53-apoptosis signaling (Perp) and caspase signaling (Casp8) pathways in the VTA of F344 rats. These results indicate that nicotine showed brain-regionspecific alterations in the antioxidant enzyme expression and induction of oxidative stress signaling pathways. The antioxidant and neuroprotective properties of nicotine have been demonstrated by reported studies, which showed that the neurotoxic and neuroprotective actions of nicotine in the health state depend on the difference in experimental models and treatment dose of nicotine (Kimura et al. 1993; Picciotto and Zoli 2008) . Guan et al. (2002) showed that a low dose of nicotine (10 μM) provided a protective effect against ROS production, whereas a high concentration of nicotine (10 mM) induced oxidative-stress-mediated apoptosis in PC12 cells. In contrast, Linert et al. (1999) showed that nicotine had no effect on the formation of ROS or neuronal damage in the neocortex, hippocampus, and neostriatum of rats. The same group also showed the beneficial effects of nicotine in neocortical primary cells and indicated the possible effect of nicotine in formation of 6-OHDA through interaction between dopamine and Fenton's reagents. Soto-Otero et al. (2002) reported that nicotine increased the production of hydrogen peroxide by 6-OHDA autoxidation that resulted in an increase in the neurotoxicity. Chronic nicotine exposure increases the dopamine release from VTA to NAc by regulating nicotinic acetylcholine receptors from VTA. Excessive levels of synaptic dopamine are eliminated by monoamine oxidase (MAO) which is associated with the formation of cellular oxidants (hydrogen peroxide) and oxidative stress induction. Increased production of hydrogen peroxide is scavenged by GSHcentered antioxidant enzymes that protect neurons against oxidative stress (Menon 2001b) . Therefore, brain regions with high concentrations of dopamine are more vulnerable to oxidative stress due to dopamine turnover and subsequent oxidation processes. Consistent with the literature, our results indicate that nicotine has a selective effect on oxidative stress mechanisms in the mesolimbic system. Nicotine increases the antioxidant defense mechanisms by regulating the expression of Sod1 in the NAc and GSHs in the VTA. However, a moderate dose of nicotine decreases the expression of Sod2 that results in an enhancement in the expression of genes related to apoptosis signaling (Casp8 and Perp) in the VTA.
Conclusion
Our study focused on the characterization of synergistic effects between HIV-1 proteins and nicotine on mitochondrial function, oxidative stress, and apoptosis signaling in the dopaminergic midbrain regions. Our results indicate a novel interaction between nicotine and HIV-1 proteins in the mesolimbic brain regions where a moderate dose of chronic nicotine treatment partially attenuated the HIV-1 proteins, induced oxidative-stress-mediated apoptosis by increasing the Sod1 expression, and decreased the caspase signaling in the NAc. However, nicotine potentiated the effect of HIV-1 proteins in the VTA by decreasing the expression of genes in the antioxidant defense system and by increasing the levels of genes associated with apoptosis signaling. Further, we showed that nicotine exhibits a dual effect on the antioxidant defense system and oxidative-stress-mediated apoptosis signaling in a brain-region-specific manner in F344 rats. These findings suggest that nicotine enhances the detrimental effects of HIV-1 proteins in the VTA and partially attenuates this effect in the NAc. Our findings need further investigation to elucidate the mechanisms of the possible interaction between nicotine and HIV-1 proteins in the dopaminergic pathways in response to psychostimulant drugs of abuse.
